196 related articles for article (PubMed ID: 22739561)
21. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
[TBL] [Abstract][Full Text] [Related]
22. Should a cardioverter-defibrillator be implanted in an Andersen-Tawil syndrome patient with severe ventricular arrhythmias and syncope?
Bienias P; Kostera-Pruszczyk A; Bieganowska K; Miszczak-Knecht M; Pruszczyk P
Kardiol Pol; 2014; 72(8):755. PubMed ID: 25155849
[No Abstract] [Full Text] [Related]
23. Andersen-Tawil syndrome with early fixed myopathy.
Lefter S; Hardiman O; Costigan D; Lynch B; McConville J; Hand CK; Ryan AM
J Clin Neuromuscul Dis; 2014 Dec; 16(2):79-82. PubMed ID: 25415519
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.
Ünal Yüksekgönül A; Azak E; Akalın A; Ertuğrul İ; Kılıç E; Utine GE; Karagöz T
Eur J Med Genet; 2022 Jun; 65(6):104499. PubMed ID: 35429663
[TBL] [Abstract][Full Text] [Related]
25. Resuscitated sudden cardiac death in Andersen-Tawil syndrome.
Airey KJ; Etheridge SP; Tawil R; Tristani-Firouzi M
Heart Rhythm; 2009 Dec; 6(12):1814-7. PubMed ID: 19959136
[No Abstract] [Full Text] [Related]
26. Combined inhibition of Na⁺ and Ca²⁺ channels: a novel paradigm for the treatment of incessant ventricular arrhythmias in Andersen-Tawil syndrome.
Janson CM; Poelzing S; Shah MJ
Heart Rhythm; 2014 Feb; 11(2):318-20. PubMed ID: 24211314
[No Abstract] [Full Text] [Related]
27. Novel de novo mutation in the KCNJ2 gene in a patient with Andersen-Tawil syndrome.
Kim JB; Chung KW
Pediatr Neurol; 2009 Dec; 41(6):464-6. PubMed ID: 19931173
[TBL] [Abstract][Full Text] [Related]
28. Rarity and phenotypic heterogeneity provide challenges in the diagnosis of Andersen-Tawil syndrome: Two cases presenting with ECGs mimicking catecholaminergic polymorphic ventricular tachycardia (CPVT).
Tully I; Atherton J; Hunt L; Ingles J; Semsarian C; McGaughran J
Int J Cardiol; 2015 Dec; 201():473-5. PubMed ID: 26322597
[No Abstract] [Full Text] [Related]
29. A Girl with Palpitations and Periodic Weakness.
Samanta D
Indian J Pediatr; 2019 May; 86(5):480. PubMed ID: 30656561
[No Abstract] [Full Text] [Related]
30. Failure of radiofrequency catheter ablation and success of flecainide to suppress premature ventricular contractions in Andersen-Tawil syndrome: A case report.
Yilmaz S; Kanat S
J Electrocardiol; 2021; 68():37-40. PubMed ID: 34311212
[TBL] [Abstract][Full Text] [Related]
31. Coincidence of Andersen-Tawil syndrome and Marfan syndrome: A case report.
Krych M; Ponińska J; Bilińska ZT; Płoski R; Biernacka EK
Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12624. PubMed ID: 30672637
[TBL] [Abstract][Full Text] [Related]
32. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
Ergül Y; Özgür S; Onan SH; Tuzcu V
Turk Kardiyol Dern Ars; 2018 Dec; 46(8):718-722. PubMed ID: 30516532
[TBL] [Abstract][Full Text] [Related]
33. The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy.
O'Mahony C; Lambiase PD; Rahman SM; Cardona M; Calcagnino M; Quarta G; Tsovolas K; Al-Shaikh S; McKenna W; Elliott P
Europace; 2012 May; 14(5):724-33. PubMed ID: 22094454
[TBL] [Abstract][Full Text] [Related]
34. The Twiddling Andersen.
Jefferies JL; Kim JJ; Belmont JW; Friedman RA
Tex Heart Inst J; 2009; 36(4):349-51. PubMed ID: 19693314
[TBL] [Abstract][Full Text] [Related]
35. [A new type of periodic paralysis: Andersen-Tawil syndrome].
Pouget J
Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
[TBL] [Abstract][Full Text] [Related]
36. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism.
Hasegawa K; Ohno S; Kimura H; Itoh H; Makiyama T; Yoshida Y; Horie M
Clin Genet; 2015 Mar; 87(3):279-83. PubMed ID: 24635491
[TBL] [Abstract][Full Text] [Related]
37. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
Tani Y; Miura D; Kurokawa J; Nakamura K; Ouchida M; Shimizu K; Ohe T; Furukawa T
J Mol Cell Cardiol; 2007 Aug; 43(2):187-96. PubMed ID: 17582433
[TBL] [Abstract][Full Text] [Related]
38. Obstetric management of a patient with Andersen-Tawil syndrome: A case report.
Inagaki M; Tatsumi T; Yomogita H; Hirose A; Kubo T; Sekiguchi M; Miyasaka N
J Obstet Gynaecol Res; 2021 Jan; 47(1):446-451. PubMed ID: 33205612
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
40. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
Lu CW; Lin JH; Rajawat YS; Jerng H; Rami TG; Sanchez X; DeFreitas G; Carabello B; DeMayo F; Kearney DL; Miller G; Li H; Pfaffinger PJ; Bowles NE; Khoury DS; Towbin JA
J Med Genet; 2006 Aug; 43(8):653-9. PubMed ID: 16571646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
